StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.92+0.02 (+1.05%)

Close on Nov 19, 2026Market cap $152.93MP/E –Yield –

NervGen Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for NervGen Pharma

NervGen Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NervGen Pharma figures

See a number that looks wrong?